Dr. Amber Lee Degryse, MD

Dr. Degryse practices at Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital.

Dr. Degryse's NPI, 1447307236, was assigned on January 4, 2007. Dr. Degryse graduated from University of South Florida College of Medicine in 2004. Dr. Degryse holds Georgia license 065537.

Dr. Degryse's primary practice is Northside Hospital Atlanta, at 1000 Johnson Ferry Road, NE, Atlanta, GA 30342 in Fulton County. The practice phone is (404) 851-8000.

Dr. Degryse's primary practice is Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital. Dr. Degryse is also affiliated with Northside Hospital Forsyth. The medical group on file is Northside Hospital Primary Care. Dmand AI also links Dr. Degryse to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Degryse practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Degryse's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Degryse is licensed in Georgia.

CMS data shows 279 Medicare services from Dr. Degryse across 5 procedure codes in 2024, for 135 Medicare patients. Medicare paid $31,997 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 135 Medicare patients who saw Dr. Degryse in 2024. The largest group is 75 to 84, with 59 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 3.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Degryse's median patient age at 73, with 56% women.

In 2024, Dr. Degryse wrote 41 Medicare Part D claims. 27% of them were for generic drugs. CMS names the drug for 23 of them, across 2 drugs with 11 or more claims each, at $7,184 in total drug cost. In 2023, CMS named 33 claims across 2 drugs.

Dr. Degryse accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Degryse, published from 2011 to 2014. 2011 was the busiest year, with 4. The most frequent topics are Bleomycin, Idiopathic Pulmonary Fibrosis and Pulmonary Surfactant-Associated Protein C. Dr. Degryse has published most often in Am J Med Sci. Dr. Degryse's most frequent co-authors are James Loyd, MD, Chad Stephen Boomershine, MD, PhD and Peter Fredrick Crossno, MD.

CMS Open Payments shows 106 general payments to Dr. Degryse from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. GlaxoSmithKline, LLC. paid the most, $403.

Dr. Degryse graduated from University of South Florida College of Medicine in 2004.